In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Laboratory Automation Workcells
... at a CAGR of 5.6% over the analysis period 2024-2030. Hardware & Software, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.5 Billion by the end ... Read More
-
Hematology Testing Products
... at a CAGR of 4.4% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$9.8 Billion by the end ... Read More
-
Pregnancy and Fertility Testing Products
... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 10.7% CAGR The Pregnancy and Fertility ... Read More
-
Over The Counter (OTC) Testing
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Glucose Monitoring Tests, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.7 ... Read More
-
Molecular Quality Controls
... at a CAGR of 5.0% over the analysis period 2024-2030. Independent Controls, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$211.3 Million by the end of ... Read More
-
Atomic Spectroscopy
... CAGR of 6.9% over the analysis period 2024-2030. Pharmaceuticals & Biotechnology Testing, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$6.2 Billion by the end of ... Read More
-
Blood Group Typing
... at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$2.8 Billion by the end of the ... Read More
-
Hereditary Testing
... CAGR of 6.2% over the analysis period 2024-2030. Preimplantation Genetic Diagnosis & Screening, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.6 Billion by the end ... Read More
-
Preimplantation Genetic Testing
... at a CAGR of 10.1% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$794.1 Million by the end ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of the ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Biosensors
... 7.2% over the analysis period 2024-2030. Non-wearable, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.3 Billion by the end of the analysis period. Growth in ... Read More
-
Blood Gas and Electrolyte Analyzers
... Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$823.6 Million by ... Read More
-
Clinical Chemistry Analyzers
... at a CAGR of 4.9% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$12.5 Billion by the end of the ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More
-
Research ELISA (Enzyme-Linked Immunosorbent Assay)
... Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ELISA Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$478.6 Million ... Read More
-
Testing Laboratories
... CAGR of 7.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$30.0 Billion While China is Forecast to Grow at 9.6% CAGR The Testing Laboratories market in the U.S. is estimated at ... Read More
-
Companion Diagnostics
... CAGR of 0.3% over the analysis period 2024-2030. Assay kits & Reagents, one of the segments analyzed in the report, is expected to record a -0.4% CAGR and reach US$9.7 Billion by the end of ... Read More
-
High Content Screening (HCS)
... 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$1.0 Billion by the end ... Read More
-
Cell Surface Markers
... at a CAGR of 9.4% over the analysis period 2024-2030. Antibodies, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$981.1 Million by the end of the ... Read More
-
Hemostasis Products
... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More
-
Testing and Analysis Services
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Elemental, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the end ... Read More
-
Toxicology Testing Services
... at a CAGR of 8.4% over the analysis period 2024-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More
Research Assistance
